Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

373 trials

NCT06692530
Recruiting
Asylumseekers Experiencing Paranoid Delusions: A Virtual Reality Study
Not applicable · Netherlands · 1 site
Registry update: 2 Apr 2025
NCT06642675
Recruiting
nTMS for Negative Symptom in Schizophrenia
Not applicable · China · 1 site
Registry update: 5 Dec 2025
NCT06729541
Recruiting
Development and Application of Precision Treatment Strategies for Common Mental Disorders
Not applicable · China · 1 site
Registry update: 12 Dec 2024
NCT06484387
Recruiting
Study of Intra- and Interpersonal Multimodal Synchronizations in a Social Interaction in Individuals with a Diagnosis of Schizophrenia.
Not applicable · France · 1 site
Registry update: 9 Dec 2024
NCT06651112
Recruiting
The ATP Project (Antipsychotic-TEP-Psychosis)
Not applicable · Canada · 1 site
Registry update: 26 Oct 2026
NCT06597864
Recruiting
Seven-step Phenomenological Psychotherapy for Self-disorder - a Pilot Study
Not applicable · Norway · 2 sites
Registry update: 9 Dec 2025
NCT06568081
Recruiting
SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study
Not applicable · United Kingdom · 1 site
Registry update: 11 Aug 2026
NCT07493551
Recruiting
A Bioequivalence Study of PP3M in Patients With Schizophrenia
Not applicable · China · 1 site
Registry update: 25 Mar 2026
NCT06613334
Recruiting
Voice-Based Biomarkers: A Novel Approach to Monitoring and Predicting Schizophrenia Relapses
Not applicable · France · 2 sites
Registry update: 21 Sept 2026
NCT06634641
Recruiting
Clozapine-related Immunodeficiency in Parkinsons Disease
Phase 4 · France · 1 site
Registry update: 19 Nov 2025
NCT06585787
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Phase 3 · Argentina, Belgium, Bulgaria, Brazil, China, Germany, Spain, France, Greece, Croatia, Hungary, Israel, India, Italy, Japan, South Korea, Poland, Puerto Rico, Portugal, Romania, Serbia, Slovakia, Ukraine, United States · 278 sites
Registry update: 27 Oct 2026
NCT06574360
Recruiting
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia
Phase 2 · Taiwan · 1 site
Registry update: 24 Mar 2026
NCT06556251
Recruiting
Effectiveness of a Digital Platform in Engagement and Prognosis of Patients in an Early Intervention Pychosis Programme
Not applicable · Spain · 1 site
Registry update: 25 May 2025
NCT06058702
Recruiting
Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
Phase 1 · United States · 1 site
Registry update: 2 Sept 2026
NCT06969755
Recruiting
Biomarkers to Enhance Early Schizophrenia Treatment
Phase 4 · Canada, United States · 5 sites
Registry update: 31 Jul 2026
NCT06700902
Recruiting
Taking Action for College Students
Not applicable · United States · 1 site
Registry update: 29 Dec 2025
NCT05770375
Recruiting
Tolerability of MDMA in Schizophrenia
Phase 1/2 · United States · 1 site
Registry update: 17 Jul 2026
NCT06608706
Recruiting
The Key to Integrated Trauma Treatment in Psychosis Trial
Not applicable · Norway · 11 sites
Registry update: 24 Apr 2026
NCT06540833
Recruiting
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Phase 2 · Bulgaria, Czechia, Spain, Croatia, Italy, Poland, Romania, Serbia, Slovakia, United States · 71 sites
Registry update: 3 Nov 2026
NCT06286202
Recruiting
Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE) a Community-Based Cognitive Remediation Trial
Not applicable · Singapore · 5 sites
Registry update: 27 Jan 2026

Ordered by registry start date. Freshness and sponsorship never change the order.